KR100879489B1 - 캄프토테신 유도체 - Google Patents
캄프토테신 유도체 Download PDFInfo
- Publication number
- KR100879489B1 KR100879489B1 KR1020037009586A KR20037009586A KR100879489B1 KR 100879489 B1 KR100879489 B1 KR 100879489B1 KR 1020037009586 A KR1020037009586 A KR 1020037009586A KR 20037009586 A KR20037009586 A KR 20037009586A KR 100879489 B1 KR100879489 B1 KR 100879489B1
- Authority
- KR
- South Korea
- Prior art keywords
- cpt
- hydroxy
- alkyl
- compound
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26304001P | 2001-01-18 | 2001-01-18 | |
| US60/263,040 | 2001-01-18 | ||
| US09/797,769 | 2001-03-01 | ||
| US09/797,769 US6350756B1 (en) | 2001-01-18 | 2001-03-01 | Camptothecin derivatives |
| PCT/US2001/050288 WO2002056885A1 (en) | 2001-01-18 | 2001-12-20 | Camptothecin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20040035588A KR20040035588A (ko) | 2004-04-29 |
| KR100879489B1 true KR100879489B1 (ko) | 2009-01-20 |
Family
ID=26949624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020037009586A Expired - Fee Related KR100879489B1 (ko) | 2001-01-18 | 2001-12-20 | 캄프토테신 유도체 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6350756B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1353673B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4243484B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100879489B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN100406013C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE359786T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002243367B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2434747C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60128003T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2284716T3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL156967A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03006405A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ527078A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002056885A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6350756B1 (en) | 2001-01-18 | 2002-02-26 | California Pacific Medical Center | Camptothecin derivatives |
| US6403604B1 (en) * | 2001-03-01 | 2002-06-11 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| US6855720B2 (en) * | 2001-03-01 | 2005-02-15 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| US6699875B2 (en) | 2002-05-06 | 2004-03-02 | The Stehlin Foundation For Cancer Research | Cascade esters of camptothecins and methods of treating cancer using these compounds |
| US6703399B2 (en) * | 2002-05-06 | 2004-03-09 | The Stehlin Foundation For Cancer Research | Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds |
| AU2003243397A1 (en) * | 2002-06-03 | 2003-12-19 | California Pacific Medical Center | Homo-camptothecin derivatives |
| US6933302B2 (en) * | 2002-06-03 | 2005-08-23 | California Pacific Medical Center | Nitrogen-based homo-camptothecin derivatives |
| US20050129719A1 (en) * | 2003-12-15 | 2005-06-16 | Yu-Fang Hu | Concentrated emulsion formulation for silatecan |
| US7910593B2 (en) * | 2004-04-09 | 2011-03-22 | Chugai Seiyaku Kabushiki Kaisha | Water-soluble prodrugs |
| US20060003976A1 (en) * | 2004-06-04 | 2006-01-05 | Yuehua Zhang | Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds |
| TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
| WO2007048097A2 (en) * | 2005-10-20 | 2007-04-26 | California Pacific Medical Center | Anbrosteeone derivatives and method of use thereof |
| US7875602B2 (en) * | 2005-10-21 | 2011-01-25 | Sutter West Bay Hospitals | Camptothecin derivatives as chemoradiosensitizing agents |
| WO2012134446A1 (en) * | 2011-03-29 | 2012-10-04 | SUTTER WEST BAY HOSPITALS doing business as CALIFORNIA PACIFIC MEDICAL CENTER | Epiandrosterone and/or androsterone derivatives and method of use thereof |
| US10980798B2 (en) | 2011-11-03 | 2021-04-20 | Taiwan Liposome Company, Ltd. | Pharmaceutical compositions of hydrophobic camptothecin derivatives |
| TWI619496B (zh) | 2011-11-03 | 2018-04-01 | 台灣微脂體股份有限公司 | 疏水性喜樹鹼衍生物之醫藥組合物 |
| CN102516258B (zh) * | 2011-11-11 | 2014-06-25 | 正大天晴药业集团股份有限公司 | 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用 |
| CN104163823B (zh) * | 2014-04-30 | 2016-03-09 | 浙江工业大学 | 一种喜树碱与青蒿琥酯偶联物及其制备方法与应用 |
| CN110590796B (zh) * | 2018-06-12 | 2022-07-15 | 青岛海洋生物医药研究院股份有限公司 | 喜树碱衍生物及其制备方法和应用 |
| AU2020309244A1 (en) | 2019-07-11 | 2022-03-03 | Sun Pharma Advanced Research Company Ltd. | Camptothecin derivatives with a disulfide moiety and a piperazine moiety |
| AR125473A1 (es) | 2021-04-29 | 2023-07-19 | Abbvie Inc | Conjugados de anticuerpo anti-c-met y fármaco |
| WO2023150899A1 (en) * | 2022-02-08 | 2023-08-17 | Canwell Biotech Limited | Conjugates of chemotherapy agents and tissue-binding small molecules, compositions and methods thereof |
| KR20250079213A (ko) | 2022-10-09 | 2025-06-04 | 라노바 메디신즈 리미티드 | 화합물, 조성물 및 방법 |
| CN117285540B (zh) * | 2023-09-27 | 2025-07-11 | 中国海洋大学 | 12-位取代的喜树碱衍生物及其用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965566A (en) | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| WO2000067801A2 (en) * | 1999-05-06 | 2000-11-16 | University Of Kentucky Research Foundation | Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399282A (en) * | 1979-07-10 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives |
| US4943579A (en) | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
| JP2524803B2 (ja) * | 1988-03-29 | 1996-08-14 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体およびその製造法 |
| JP2524804B2 (ja) * | 1988-03-29 | 1996-08-14 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体及びその製造法 |
| GB9320781D0 (en) | 1993-10-08 | 1993-12-01 | Erba Carlo Spa | Polymer-bound camptothecin derivatives |
| US5919455A (en) | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5646159A (en) | 1994-07-20 | 1997-07-08 | Research Triangle Institute | Water-soluble esters of camptothecin compounds |
| GB9504065D0 (en) | 1995-03-01 | 1995-04-19 | Pharmacia Spa | Poly-pyrrolecarboxamidonaphthalenic acid derivatives |
| JPH08333370A (ja) | 1995-06-08 | 1996-12-17 | Kyorin Pharmaceut Co Ltd | 水に可溶な新規フルオロエチルカンプトテシン誘導体、及びその製造方法 |
| US6339091B1 (en) | 1995-06-21 | 2002-01-15 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Comptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| WO1997019085A1 (en) | 1995-11-22 | 1997-05-29 | Research Triangle Institute | Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties |
| US6096336A (en) | 1996-01-30 | 2000-08-01 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| US5731316A (en) | 1996-01-30 | 1998-03-24 | The Stehlin Foundation For Cancer Research | Derivatives of camptothecin and methods of treating cancer using these derivatives |
| DE69728152T2 (de) | 1996-08-19 | 2004-08-05 | Bionumerik Pharmaceuticals, Inc., San Antonio | Hoch-lipophile campothecin-derivate |
| AU739028B2 (en) | 1996-09-27 | 2001-10-04 | Bristol-Myers Squibb Company | Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| WO1998014459A1 (de) | 1996-09-30 | 1998-04-09 | Bayer Aktiengesellschaft | Glycokonjugate von modifizierten camptothecin-derivaten (20-o-verknüpfung) |
| SG88737A1 (en) | 1996-10-30 | 2002-05-21 | Tanabe Seiyaku Co | S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
| UA57757C2 (uk) | 1996-12-20 | 2003-07-15 | Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.) | Аналоги камптотецину, спосіб їх отримання (варіанти) і фармацевтична композиція |
| US6169080B1 (en) * | 1997-02-13 | 2001-01-02 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
| DE69834923T2 (de) * | 1997-02-14 | 2006-10-19 | Bionumerik Pharmaceuticals, Inc., San Antonio | Hochgradig lipophile camptothecin-derivate |
| ID23424A (id) | 1997-05-14 | 2000-04-20 | Bayer Ag | Glikokonjugat dari 20(s)-kamptotesin |
| GB9721070D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Bioactive derivatives of camptothecin |
| US6153655A (en) | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| US6057303A (en) | 1998-10-20 | 2000-05-02 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic Camptothecin derivatives |
| US6207832B1 (en) | 1999-04-09 | 2001-03-27 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| AU4822500A (en) | 1999-05-04 | 2000-11-17 | Bionumerik Pharmaceuticals, Inc. | Novel highly lipophilic camptothecin analogs |
| US6350756B1 (en) | 2001-01-18 | 2002-02-26 | California Pacific Medical Center | Camptothecin derivatives |
| US6403604B1 (en) | 2001-03-01 | 2002-06-11 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| GB0119578D0 (en) | 2001-08-10 | 2001-10-03 | Pharmacia & Upjohn Spa | Fluoro linkers |
-
2001
- 2001-03-01 US US09/797,769 patent/US6350756B1/en not_active Ceased
- 2001-12-20 JP JP2002557393A patent/JP4243484B2/ja not_active Expired - Fee Related
- 2001-12-20 EP EP01989260A patent/EP1353673B1/en not_active Expired - Lifetime
- 2001-12-20 AT AT01989260T patent/ATE359786T1/de not_active IP Right Cessation
- 2001-12-20 AU AU2002243367A patent/AU2002243367B2/en not_active Ceased
- 2001-12-20 DE DE60128003T patent/DE60128003T2/de not_active Expired - Lifetime
- 2001-12-20 MX MXPA03006405A patent/MXPA03006405A/es active IP Right Grant
- 2001-12-20 CN CNB018227384A patent/CN100406013C/zh not_active Expired - Fee Related
- 2001-12-20 ES ES01989260T patent/ES2284716T3/es not_active Expired - Lifetime
- 2001-12-20 KR KR1020037009586A patent/KR100879489B1/ko not_active Expired - Fee Related
- 2001-12-20 WO PCT/US2001/050288 patent/WO2002056885A1/en not_active Ceased
- 2001-12-20 IL IL15696701A patent/IL156967A0/xx unknown
- 2001-12-20 NZ NZ527078A patent/NZ527078A/en not_active IP Right Cessation
- 2001-12-20 CA CA2434747A patent/CA2434747C/en not_active Expired - Fee Related
-
2003
- 2003-01-16 US US10/346,835 patent/USRE39707E1/en not_active Expired - Lifetime
- 2003-07-16 IL IL156967A patent/IL156967A/en not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965566A (en) | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| WO2000067801A2 (en) * | 1999-05-06 | 2000-11-16 | University Of Kentucky Research Foundation | Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040035588A (ko) | 2004-04-29 |
| WO2002056885A1 (en) | 2002-07-25 |
| CN1553802A (zh) | 2004-12-08 |
| AU2002243367B2 (en) | 2006-10-05 |
| DE60128003T2 (de) | 2007-12-27 |
| US6350756B1 (en) | 2002-02-26 |
| CA2434747C (en) | 2012-02-07 |
| EP1353673B1 (en) | 2007-04-18 |
| JP4243484B2 (ja) | 2009-03-25 |
| CA2434747A1 (en) | 2002-07-25 |
| EP1353673A1 (en) | 2003-10-22 |
| IL156967A (en) | 2009-08-03 |
| ATE359786T1 (de) | 2007-05-15 |
| DE60128003D1 (en) | 2007-05-31 |
| USRE39707E1 (en) | 2007-06-26 |
| ES2284716T3 (es) | 2007-11-16 |
| CN100406013C (zh) | 2008-07-30 |
| IL156967A0 (en) | 2004-02-08 |
| JP2004521105A (ja) | 2004-07-15 |
| NZ527078A (en) | 2005-12-23 |
| MXPA03006405A (es) | 2004-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20040035588A (ko) | 캄프토테신 유도체 | |
| US8158809B2 (en) | Podophyllotoxin derivatives | |
| AU2002243367A1 (en) | Camptothecin derivatives | |
| KR100853141B1 (ko) | 질소계 캄토테신 유도체 | |
| KR101320160B1 (ko) | 화학방사선증감제로서의 캄프토테신 유도체 | |
| US6855720B2 (en) | Nitrogen-based camptothecin derivatives | |
| US20040063740A1 (en) | Nitrogen-based homo-camptothecin derivatives | |
| US20040034050A1 (en) | Homo-camptothecin derivatives | |
| AU2002250039A1 (en) | Nitrogen-based camptothecin derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| FPAY | Annual fee payment |
Payment date: 20120112 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20130114 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20130114 |